Stocks Overview

LAST PRICE
42.6900
TODAY'S CHANGE (%)
Trending Down-0.3600 (-0.8362%)

Bid / Lots
42.4000/ 1
Ask / Lots
45.3000/ 1
Open / Previous Close
43.0100 / 43.0500
Day Range
Low 42.2600
High 43.3550
52 Week Range
Low 41.0100
High 76.9800
Volume
455,665
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 43.1
Time	Volume	IMCR
09:32 ET	9691	42.85
09:34 ET	200	42.71
09:36 ET	500	42.9
09:38 ET	600	42.96
09:39 ET	500	43.05
09:41 ET	200	43.05
09:43 ET	600	42.94
09:45 ET	300	43
09:48 ET	1500	43.06
09:50 ET	3651	43.19
09:52 ET	800	43.225
09:54 ET	100	43.22
09:56 ET	800	43.27
09:57 ET	1183	43.25
09:59 ET	200	43.16
10:01 ET	500	43.21
10:03 ET	2200	43.28
10:08 ET	200	43.23
10:10 ET	1800	42.97
10:12 ET	1398	42.99
10:14 ET	800	43
10:15 ET	100	43.05
10:17 ET	200	43.04
10:19 ET	594	43.07
10:21 ET	635	42.895
10:24 ET	100	42.95
10:26 ET	200	43.1
10:28 ET	400	43.01
10:30 ET	25700	42.7
10:32 ET	30942	42.81
10:33 ET	3210	43
10:35 ET	500	42.9
10:42 ET	4700	42.945
10:44 ET	340	42.95
10:46 ET	2589	43
10:48 ET	2724	43.115
10:50 ET	606	43.02
10:51 ET	600	42.985
10:53 ET	1000	42.92
10:55 ET	600	42.97
10:57 ET	3371	43.01
11:04 ET	100	42.99
11:06 ET	4741	43.07
11:08 ET	1189	43.04
11:09 ET	100	43.04
11:15 ET	3200	42.975
11:18 ET	300	43.03
11:20 ET	100	42.98
11:24 ET	17206	42.965
11:26 ET	12251	42.895
11:27 ET	614	42.72
11:29 ET	1706	42.6504
11:31 ET	800	42.514
11:33 ET	325	42.42
11:36 ET	300	42.39
11:38 ET	459	42.35
11:40 ET	900	42.39
11:42 ET	950	42.51
11:44 ET	400	42.47
11:47 ET	150	42.42
11:51 ET	413	42.61
11:54 ET	518	42.62
11:56 ET	1428	42.595
11:58 ET	400	42.51
12:00 ET	120	42.61
12:02 ET	100	42.52
12:03 ET	1404	42.63
12:07 ET	3792	42.84
12:09 ET	500	42.61
12:12 ET	600	42.67
12:14 ET	200	42.73
12:16 ET	1450	42.795
12:18 ET	600	42.815
12:20 ET	206	42.84
12:21 ET	500	42.84
12:23 ET	238	42.84
12:27 ET	100	42.87
12:30 ET	100	42.86
12:32 ET	300	42.83
12:34 ET	4328	42.95
12:36 ET	1000	42.78
12:39 ET	500	42.76
12:41 ET	102	42.76
12:43 ET	2660	42.8
12:45 ET	200	42.77
12:48 ET	1100	42.63
12:50 ET	400	42.61
12:52 ET	900	42.75
12:54 ET	100	42.7996
12:59 ET	400	42.76
01:01 ET	3189	42.87
01:06 ET	2500	42.84
01:10 ET	200	42.835
01:12 ET	949	42.92
01:14 ET	3400	43.13
01:15 ET	2500	43.12
01:17 ET	300	43.15
01:19 ET	10544	43.11
01:21 ET	500	43
01:24 ET	100	42.97
01:26 ET	2875	43
01:30 ET	200	42.95
01:32 ET	3512	43.015
01:35 ET	1582	42.84
01:37 ET	100	42.85
01:39 ET	423	42.81
01:42 ET	1168	42.86
01:44 ET	200	42.89
01:46 ET	500	42.95
01:48 ET	412	42.88
01:51 ET	840	42.865
01:53 ET	400	42.91
02:04 ET	100	42.89
02:06 ET	3290	42.89
02:08 ET	401	42.89
02:09 ET	2297	42.89
02:11 ET	100	42.905
02:13 ET	199	42.92
02:15 ET	200	42.97
02:18 ET	3862	42.895
02:20 ET	1579	42.73
02:22 ET	22321	42.71
02:26 ET	1075	42.77
02:29 ET	287	42.71
02:31 ET	1289	42.66
02:33 ET	500	42.72
02:36 ET	208	42.73
02:38 ET	100	42.75
02:40 ET	400	42.77
02:42 ET	500	42.78
02:45 ET	200	42.72
02:49 ET	300	42.74
02:51 ET	292	42.74
02:54 ET	475	42.77
02:56 ET	500	42.7
03:00 ET	200	42.79
03:02 ET	200	42.73
03:05 ET	2189	42.705
03:07 ET	200	42.7
03:09 ET	818	42.66
03:12 ET	400	42.66
03:14 ET	200	42.66
03:16 ET	400	42.655
03:18 ET	400	42.69
03:20 ET	2722	42.69
03:23 ET	34772	42.85
03:25 ET	1154	42.95
03:27 ET	1100	42.94
03:30 ET	2332	42.98
03:32 ET	300	42.955
03:34 ET	700	42.98
03:36 ET	3067	42.975
03:38 ET	800	42.97
03:39 ET	900	43
03:41 ET	6091	43.1
03:43 ET	6610	42.965
03:45 ET	3161	42.985
03:48 ET	3791	42.865
03:50 ET	700	42.81
03:52 ET	3159	42.89
03:54 ET	1000	42.81
03:56 ET	3304	42.72
03:57 ET	6135	42.72
03:59 ET	3918	42.69

Data delayed at least 15 minutes.

Yesterday
- DJ Immunocore Holdings Price Target Maintained With a $100.00/Share by HC Wainwright & Co., from 11:45AM ET on Wednesday Jun 05, 2024 by Dow Jones
  11:45AM ET on Wednesday Jun 05, 2024 by Dow Jones
Jun 3, 2024
- DJ Immunocore Holdings Price Target Maintained With a $81.00/Share by Needham, from 6:31AM ET on Monday Jun 03, 2024 by Dow Jones
  6:31AM ET on Monday Jun 03, 2024 by Dow Jones
Jun 1, 2024
- Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response, from 8:00AM ET on Saturday Jun 01, 2024 by Dow Jones
  8:00AM ET on Saturday Jun 01, 2024 by Dow Jones
May 31, 2024
- Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024, from 4:05PM ET on Friday May 31, 2024 by Dow Jones
  4:05PM ET on Friday May 31, 2024 by Dow Jones
May 30, 2024
- Immunocore to present at the Jefferies Global Healthcare Conference, from 4:00PM ET on Thursday May 30, 2024 by Dow Jones
  4:00PM ET on Thursday May 30, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesIMCR Immunocore Holdings PLC	2.4B	-35.6x	---
United StatesLGND Ligand Pharmaceuticals Inc	1.5B	15.7x	-12.71%
United StatesINVA Innoviva Inc	986.0M	7.5x	-9.89%
United StatesEOLS Evolus Inc	809.6M	-11.9x	---
United StatesCORT Corcept Therapeutics Inc	3.1B	32.2x	+9.80%
United StatesAVDL Avadel Pharmaceuticals PLC	1.5B	-8.2x	---
As of 2024-06-06

Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a clinical-stage pipeline of wholly owned and partnered programs across three different therapeutic areas: oncology, infectious diseases, and autoimmune and inflammation diseases. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include IMC-F106C, IMC-F115C, IMC-F119C, IMC-F117C, IMC-F113V, IMC-I109V, IMC-SII8AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, lung, gastric and others.

Contact Information

Headquarters: 90 Park Drive, Milton Park, AbingdonABINGDON, United Kingdom OX14 4RY
Phone: 123-543-8600
Fax: ---

Executives

Independent Chairman of the Board: John Bell
Chief Executive Officer, Director: Bahija Jallal
Chief Financial Officer, Head of Strategy: Brian Di Donato
Chief Human Resource Officer: Tina St Leger
Head of Research and Development: David Berman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$2.4B
Revenue (TTM)	$265.8M
Shares Outstanding	50.0M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	---
EPS	$-1.20
Book Value	$7.42
P/E Ratio	-35.6x
Price/Sales (TTM)	9.2
Price/Cash Flow (TTM)	---
Operating Margin	-24.46%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Immunocore Holdings PLC
NASDAQ:IMCRUnited States

Search Criteria

Charts

Recent News

Yesterday

DJ Immunocore Holdings Price Target Maintained With a $100.00/Share by HC Wainwright & Co., from 11:45AM ET on Wednesday Jun 05, 2024 by Dow Jones

Jun 3, 2024

DJ Immunocore Holdings Price Target Maintained With a $81.00/Share by Needham, from 6:31AM ET on Monday Jun 03, 2024 by Dow Jones

Jun 1, 2024

Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response, from 8:00AM ET on Saturday Jun 01, 2024 by Dow Jones

May 31, 2024

Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting PRAME, in immune checkpoint pre-treated cutaneous melanoma patients at ASCO 2024, from 4:05PM ET on Friday May 31, 2024 by Dow Jones

May 30, 2024

Immunocore to present at the Jefferies Global Healthcare Conference, from 4:00PM ET on Thursday May 30, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar